2021 LUNGevity VA Research Scholar Award

Organization
LUNGevity Foundation
Type
Foundation
Application Due Date
02-24-2021
Comments
LOIs due 2/24/21. Full application due (by invitation only): May 10, 2021, 11:59 pm EDT
Brief Description

LUNGevity’s VA Research Scholar Award for Lung Cancer Translational Research program supports fellows interested in lung cancer research within the Department of Veterans Affairs.

  • Applicants must hold a doctoral degree and either be pursuing a postdoctoral fellowship program or be juniorfaculty within the first five years of their faculty appointment and plan to pursue a career in lung cancer research at a Veterans Affairs institution (or an academic institution with an affiliation with a local Veterans Affairs institution)
  • The VA Research Scholar Award is a mentored award; a mentoring plan is part of the required submission

Projects that will be funded in 2021 are expected to have a direct impact on the early detection of lung cancer or on the outcomes of lung cancer, or to provide a clear conceptual or experimental foundation for the future development of methods for early detection and/or individualized treatment, including through targeted therapy and immunotherapy. In addition, the proposed research must have relevance to the veteran population, related to either screening/early detection or treatment of lung cancer.

The VA Research Scholar Award may be for a maximum of $100,000:

  • $50,000 per year for two years (direct costs only)
  • Annual milestones must be met

Note: LUNGevity will grant only one VA Research Scholar Award per institution.

LUNGevity uses a two-step application process:

  1. A letter of intent (LOI), with a brief overview of the proposed project and biographical information
  2. A full application with an extended narrative about the project, as well as supporting information and documentation. (Because there are a limited number of awards, only a subset of applicants is invited to submit a full application after the LOI review is completed.)